Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
16.81
+0.73 (4.51%)
Nov 21, 2024, 12:34 PM EST - Market open
CRBP Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$65.86
Upside
+291.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +376.05% | Sep 23, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $85 → $40 | Strong Buy | Maintains | $85 → $40 | +138.02% | Sep 20, 2024 |
| Wedbush | Wedbush | Buy Maintains $85 → $51 | Buy | Maintains | $85 → $51 | +203.48% | Sep 20, 2024 |
| Mizuho | Mizuho | Buy Reiterates $74 | Buy | Reiterates | $74 | +340.35% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +387.95% | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +387.95% | Aug 28, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $82 | Buy | Reiterates | $82 | +387.95% | Aug 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $80 → $88 | Buy | Maintains | $80 → $88 | +423.65% | Aug 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +376.05% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +376.05% | Jul 22, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $80 | Buy | Reiterates | $80 | +376.05% | Jul 10, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $85 | Strong Buy | Initiates | $85 | +405.80% | Jun 26, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $77 → $82 | Buy | Maintains | $77 → $82 | +387.95% | Jun 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $80 | Buy | Maintains | $60 → $80 | +376.05% | Jun 3, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $77 | Buy | Initiates | $77 | +358.20% | May 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $58 → $60 | Buy | Maintains | $58 → $60 | +257.04% | May 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.